PCSK9 genome editing reduces LDL

Researchers from University of Pennsylvania and Precision BioSciences Inc. (Durham, N.C.) led by gene therapy pioneer James Wilson showed that inhibiting PCSK9 through genome editing

Read the full 250 word article

User Sign In